Sexually Transmitted Diseases (STD) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4170613
- 104 Pages
- February 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Sexually Transmitted Diseases (STD) Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Sexually Transmitted Diseases (STD) Testing market segmented into
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others
Based on the end-use, the global Sexually Transmitted Diseases (STD) Testing market classified into
Laboratory Testing
Point of Care (POC) Testing
Based on geography, the global Sexually Transmitted Diseases (STD) Testing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING INDUSTRY
2.1 Summary about Sexually Transmitted Diseases (STD) Testing Industry
2.2 Sexually Transmitted Diseases (STD) Testing Market Trends
2.2.1 Sexually Transmitted Diseases (STD) Testing Production & Consumption Trends
2.2.2 Sexually Transmitted Diseases (STD) Testing Demand Structure Trends
2.3 Sexually Transmitted Diseases (STD) Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Chlamydia
4.2.2 Syphilis
4.2.3 Gonorrhea
4.2.4 Herpes Simplex Virus
4.2.5 Human Papilloma Virus
4.2.6 Human Immunodeficiency Virus
4.2.7 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Laboratory Testing
4.3.2 Point of Care (POC) Testing
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Chlamydia
5.2.2 Syphilis
5.2.3 Gonorrhea
5.2.4 Herpes Simplex Virus
5.2.5 Human Papilloma Virus
5.2.6 Human Immunodeficiency Virus
5.2.7 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Laboratory Testing
5.3.2 Point of Care (POC) Testing
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Chlamydia
6.2.2 Syphilis
6.2.3 Gonorrhea
6.2.4 Herpes Simplex Virus
6.2.5 Human Papilloma Virus
6.2.6 Human Immunodeficiency Virus
6.2.7 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Laboratory Testing
6.3.2 Point of Care (POC) Testing
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Chlamydia
7.2.2 Syphilis
7.2.3 Gonorrhea
7.2.4 Herpes Simplex Virus
7.2.5 Human Papilloma Virus
7.2.6 Human Immunodeficiency Virus
7.2.7 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Laboratory Testing
7.3.2 Point of Care (POC) Testing
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Chlamydia
8.2.2 Syphilis
8.2.3 Gonorrhea
8.2.4 Herpes Simplex Virus
8.2.5 Human Papilloma Virus
8.2.6 Human Immunodeficiency Virus
8.2.7 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Laboratory Testing
8.3.2 Point of Care (POC) Testing
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Chlamydia
9.2.2 Syphilis
9.2.3 Gonorrhea
9.2.4 Herpes Simplex Virus
9.2.5 Human Papilloma Virus
9.2.6 Human Immunodeficiency Virus
9.2.7 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Laboratory Testing
9.3.2 Point of Care (POC) Testing
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 ROCHE HOLDINGS
10.1.2 BIOMERIEUX
10.1.3 HOLOGIC
10.1.4 BECTON DICKINSON
10.1.5 ORASURE
10.1.6 DANAHER
10.1.7 AFFYMETRIX
10.1.8 ABBOTT LABORATORIES
10.1.9 BIO-RAD LABORATORIES
10.1.10 DIASORIN
10.2 Sexually Transmitted Diseases (STD) Testing Sales Date of Major Players (2017-2020e)
10.2.1 ROCHE HOLDINGS
10.2.2 BIOMERIEUX
10.2.3 HOLOGIC
10.2.4 BECTON DICKINSON
10.2.5 ORASURE
10.2.6 DANAHER
10.2.7 AFFYMETRIX
10.2.8 ABBOTT LABORATORIES
10.2.9 BIO-RAD LABORATORIES
10.2.10 DIASORIN
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Sexually Transmitted Diseases (STD) Testing Product Type Overview
2.Table Sexually Transmitted Diseases (STD) Testing Product Type Market Share List
3.Table Sexually Transmitted Diseases (STD) Testing Product Type of Major Players
4.Table Brief Introduction of ROCHE HOLDINGS
5.Table Brief Introduction of BIOMERIEUX
6.Table Brief Introduction of HOLOGIC
7.Table Brief Introduction of BECTON DICKINSON
8.Table Brief Introduction of ORASURE
9.Table Brief Introduction of DANAHER
10.Table Brief Introduction of AFFYMETRIX
11.Table Brief Introduction of ABBOTT LABORATORIES
12.Table Brief Introduction of BIO-RAD LABORATORIES
13.Table Brief Introduction of DIASORIN
14.Table Products & Services of ROCHE HOLDINGS
15.Table Products & Services of BIOMERIEUX
16.Table Products & Services of HOLOGIC
17.Table Products & Services of BECTON DICKINSON
18.Table Products & Services of ORASURE
19.Table Products & Services of DANAHER
20.Table Products & Services of AFFYMETRIX
21.Table Products & Services of ABBOTT LABORATORIES
22.Table Products & Services of BIO-RAD LABORATORIES
23.Table Products & Services of DIASORIN
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Sexually Transmitted Diseases (STD) Testing Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Sexually Transmitted Diseases (STD) Testing Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Sexually Transmitted Diseases (STD) Testing Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Sexually Transmitted Diseases (STD) Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
